PRICES include / exclude VAT
Homepage>BS Standards>01 GENERALITIES. TERMINOLOGY. STANDARDIZATION. DOCUMENTATION>01.040 Vocabularies>01.040.19 Testing (Vocabularies)>BS ISO 17822:2020 In vitro diagnostic test systems. Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens. Laboratory quality practice guide
Sponsored link
immediate downloadReleased: 2021-01-29
BS ISO 17822:2020 In vitro diagnostic test systems. Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens. Laboratory quality practice guide

BS ISO 17822:2020

In vitro diagnostic test systems. Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens. Laboratory quality practice guide

CURRENCY
LANGUAGE
English
Standard number:BS ISO 17822:2020
Pages:48
Released:2021-01-29
ISBN:978 0 539 16842 6
Status:Corrigendum
DESCRIPTION
This standard BS ISO 17822:2020 In vitro diagnostic test systems. Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens. Laboratory quality practice guide is classified in these ICS categories:
  • 11.100.01 Laboratory medicine in general
  • 01.040.19 Testing (Vocabularies)

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.


This product includes: